Tag: biomedical
-
Insulin Pump Shown Difficult for Many Users
An assessment of a closed-loop insulin pump system shows a sizeable proportion of first-time users stopped using its automated feature because of problems in making it work.
-
Virtual Reality Coupled with EEG for Autism
An engineering-psychology team is developing a system connecting virtual reality with brain signals in real time to improve clinical treatments for autism spectrum disorder.
-
Crispr Diagnostics Company Launches with $35M Funding
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing.
-
Celgene Adopting A.I. Drug Discovery Technology
Drug maker Celgene is gaining access to an artificial intelligence platform developed by Exscientia Ltd, to find treatment candidates for cancer and autoimmune disorders.
-
NIH Funds Natural Hearing Restoration Technology
An international group of universities and companies is designing a next-generation device to restore more natural hearing to people suffering from hearing loss.
-
FDA Chief Calls Teen Vaping an “Epidemic”
The commissioner of the Food and Drug Administration warned that the sharp rise in teen electronic cigarette use is an epidemic threatening the public health.
-
Antibacterial Sleeve Protects Against Implant Infections
A mesh envelope infused with antibiotics holding an implanted cardiac device is shown in a large-scale clinical trial to reduce the number of infections associated with those devices.
-
NIH Funding Nanodrugs to Prevent Opioid Addiction
A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis.
-
Gates Supporting Infectious Antibody Discovery
The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases.
-
Microsoft, Biotech Partner on Gene, Cell Therapies
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies.